Rockefeller Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-25,000
| Closed | -$156K | – | 4073 |
|
|
2022
Q4 | $156K | Sell |
25,000
-189,200
| -88% | -$1.18M | ﹤0.01% | 1790 |
|
|
2022
Q3 | $749K | Hold |
214,200
| – | – | ﹤0.01% | 1117 |
|
|
2022
Q2 | $631K | Sell |
214,200
-13,175
| -6% | -$38.8K | ﹤0.01% | 1174 |
|
|
2022
Q1 | $707K | Buy |
227,375
+525
| +0.2% | +$1.63K | ﹤0.01% | 1186 |
|
|
2021
Q4 | $766K | Buy |
226,850
+102,850
| +83% | +$347K | ﹤0.01% | 1151 |
|
|
2021
Q3 | $452K | Buy |
124,000
+25,000
| +25% | +$91.1K | ﹤0.01% | 1302 |
|
|
2021
Q2 | $431K | Buy |
+99,000
| New | +$431K | ﹤0.01% | 1252 |
|